product Image
DiaPlexQ™ RV16 Detection Kit (Respiratory Disease)
Model Name
-
Series
Molecular Diagnostic (Pathogen Detection)
Data
-
Manufacturer information
provider logo
SOLGENT

DiaPlexQ™ Novel Coronavirus (2019-nCoV) Detection Kit, Covid19, Corona virus

Problem with product info?
Update request
Manufacturer
SOLGENT
Brand
-
SKU
125222
Product Name
DiaPlexQ™ RV16 Detection Kit (Respiratory Disease)
Model Name
-
Size
-
Weight
-
Product Details

DiaPlexQ™ RV16 Detection Kit

Real-Time OneStep RT-PCR based assay system for simultaneous detection of 16 major respiratory viruses

CE-IVD


Viral infections are among the leading causes of respiratory disease in children. Most of these infections are caused By respiratory syncytial virus (RSV), influenza virus A or B (Inf A of Inf B), parainfluenza virus (hPIV-I, II, III and IV) rhinovirus (RV) or adenovirus (AdV). Several recently discovered viruses, such as human metapneumovirus (hMPV), as potential respiratory pathogens.




Specification

DiaPlexQ™ RV16 Detection Kit





Detection target
Set I : Parainfluenza-I (PIV-I)
Parainfluenza-II (PIV-II)
Parainfluenza-III (PIV-III)
Set IV : Enterovirus (EntV) Bocavirus (BoV) Metapneumovirus (MPV)
Set II : Influenza Virus A (Inf A)
Parrainfluenza-Ⅳ (PIV-Ⅳ)
Influenza virus B (Inf B)
Set V : Beta Coronavirus OC43 (CoV OC43) Alpha Coronavirus 229E/NL63 (CoV 229E/NL63) MERS-CoV
Set III : Adenovirus (AdV) Respiratory syncytial virus (RSV A & B) Rhinovirus (RV A/B/C)
RegistrationCE-IVD
Detection technologyReal-Time OneStep RT-PCR
Specimen typeNasopharyngeal swab, sputum(corona MERS)
Analytical sensitivity10 - 10² copies
Compatible instruments*ABI 7500 / 7500 Fast Real-Time PCR System (Applied Biosystems)
CFX96™ Real-Time PCR System (Bio-Rad)
PCR running time~ 2 hrs




Features

- Simple & Rapid detection system : OneStep Multiplex qRT-PCR based detection

- HotStart PCR system : Ultra high specific and sensitive result

- Reliable system : Automatic PCR control

- Positive control included





Experimental








Citation&Papers

Fouchier RAV, Munster A, Wallenstein TM, Bestebroer S, Herfst D, Smith GF, et al. J Virol.

2002;79:2814-2822

Lamb RA, Krug R. Field Virology, third ed.

Lippincott-Raven Philadelphia. 1996; 1353-1395.

Ha Y, Stevens, DJ, Wiley DC.

The EMBO Journal. 2002;21;865-875.

Russell RJ, Gamblin SJ, Haire LF, Stevens DJ, Xiao B, Ha Y, et al.

Virology. 2004;287-296.







Ordering information

TechnologyCat. No.ProductContents




Real-Time PCR
SQD50-K020 (20 reaction)



DiaPlexQ ™ RV16 Detection Kit
OneStep qRT-PCR Enzyme mix (RV16)
2X OneStep qRT-PCR Buffer (RV16)
Primer & Probe Mixture I (RV16)
Primer & Probe Mixture II (RV16)
Primer & Probe Mixture III (RV16)
Primer & Probe Mixture IV (RV16)
Primer & Probe Mixture V (RV16)
Control Template (RV16)
RNase free Water
SQD50-K100 (100 reaction)



More products
SOLGENT
DiaPlexQ™ Novel Coronavirus (2019-nCoV) Detection Kit, Covid19, Corona virus
For the past 19 years, SolGent grown as a company specialized in human molecular diagnostics projects. In celebration of its 20th anniversary, the company announced its vision of a new start, “SolGent 2.0” and is growing as a bio leader in the 4th Industrial Revolution. Sturdily amassed genome analysis technology and molecular diagnostic technology have become the prominent foundation of the molecular diagnostic market, and SolGent supply products and services with the highest quality to more than 25 countries including domestic research institutes, examination centers, medical institutions and universities. In particular, as “precision medicine,” which analyzes genomes to prevent and predict diseases, becomes a new medical paradigm, SolGent develops and supplies various genome analysis services including for cancer, and expands and applies these services to agricultural products to build the AG-BIO platform. Based on its innovative technology, SolGent develops NADPH coenzyme fixed quantity measurement products DiaPlexQ™ Novel Coronavirus (2019-nCoV) Detection Kit, Covid19, Corona virus
Inquiry